{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:39:57Z","timestamp":1792485597419,"version":"4.5.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:sec id=\"ab-noi220071-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>It is uncertain whether typical variants causing monogenic stroke are associated with cerebrovascular disease in the general population and why the phenotype of these variants varies so widely.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi220071-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the frequency of pathogenic variants in the 3 most common monogenic cerebral small vessel diseases (cSVD) and their associations with prevalent and incident stroke and dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi220071-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study is a multicenter population-based study of data from UK Biobank participants recruited in 2006 through 2010, with the latest follow-up in September 2021. A total of 9.2 million individuals aged 40 to 69 years who lived in the United Kingdom were invited to join UK Biobank, of whom 5.5% participated in the baseline assessment. Participants eligible for our study (n\u2009=\u2009454\u202f756, excluding 48\u202f569 with incomplete data) had whole-exome sequencing and available data pertaining to lacunar stroke-related diseases, namely stroke, dementia, migraine, and epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi220071-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>\n                      <jats:italic>NOTCH3, HTRA1<\/jats:italic>\n                      , and\n                      <jats:italic>COL4A1\/2<\/jats:italic>\n                      pathogenic variants in monogenic stroke; Framingham cardiovascular risk; and ischemic stroke polygenic risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi220071-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary outcomes were prevalent and incident stroke and dementia. Odds ratios (ORs) and hazard ratios (HRs) were adjusted for age, sex, ethnicity, exome sequencing batch, and top 10 genetic principal components.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi220071-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 454\u202f756 participants (208\u202f027 [45.8%] men; mean [SD] age, 56.5 [8.1] years), 973 participants carried\n                      <jats:italic>NOTCH3<\/jats:italic>\n                      variants, 546 carried\n                      <jats:italic>HTRA1<\/jats:italic>\n                      variants, and 336 carried\n                      <jats:italic>COL4A1\/2<\/jats:italic>\n                      variants. Variant carriers were at least 66% more likely to have had stroke.\n                      <jats:italic>NOTCH3<\/jats:italic>\n                      carriers had increased vascular dementia risk (OR, 5.42; 95% CI, 3.11-8.74),\n                      <jats:italic>HTRA1<\/jats:italic>\n                      carriers an increased all-cause dementia risk (OR, 2.17; 95% CI, 1.28-3.41), and\n                      <jats:italic>COL4A1\/2<\/jats:italic>\n                      carriers an increased intracerebral hemorrhage risk (OR, 3.56; 95% CI, 1.34-7.53).\n                      <jats:italic>NOTCH3<\/jats:italic>\n                      variants were associated with incident ischemic stroke and vascular dementia.\n                      <jats:italic>NOTCH3<\/jats:italic>\n                      and\n                      <jats:italic>HTRA1<\/jats:italic>\n                      variants were associated with magnetic resonance imaging markers of cSVD. Cardiovascular risk burden was associated with increased stroke risk in\n                      <jats:italic>NOTCH3<\/jats:italic>\n                      and\n                      <jats:italic>HTRA1<\/jats:italic>\n                      carriers. Variant location was also associated with risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi220071-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study, pathogenic variants associated with rare monogenic stroke were more common than expected in the general population and associated with stroke and dementia. Cardiovascular risk burden is associated with the penetrance of such variants. Our results support the hypothesis that cardiovascular risk factor control may improve disease prognosis in individuals with monogenic cSVD variants. This lays the foundation for future studies to evaluate the effect of early identification before symptom onset on mitigating stroke and dementia risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2022.3832","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T04:30:38Z","timestamp":1666845038000},"page":"1303","source":"Crossref","is-referenced-by-count":64,"title":["Association of Vascular Risk Factors and Genetic Factors With Penetrance of Variants Causing Monogenic Stroke"],"prefix":"10.1001","volume":"79","author":[{"given":"Bernard P. H.","family":"Cho","sequence":"first","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Harshfield","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Al-Thani","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Tozer","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bell","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S.","family":"Markus","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"noi220071r1","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3390\/genes12121855","article-title":"Monogenic causes of strokes.","volume":"12","author":"Chojdak-Lukasiewicz","year":"2021","journal-title":"Genes (Basel)"},{"issue":"22","key":"noi220071r2","doi-asserted-by":"publisher","first-page":"e2078","DOI":"10.1212\/WNL.0000000000006567","article-title":"Neurologic phenotypes associated with COL4A1\/2 mutations: expanding the spectrum of disease.","volume":"91","author":"Zagaglia","year":"2018","journal-title":"Neurology"},{"issue":"13","key":"noi220071r3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/WNL.0b013e31824d586c","article-title":"The minimum prevalence of CADASIL in northeast England.","volume":"78","author":"Narayan","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"noi220071r4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41436-018-0088-3","article-title":"The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant.","volume":"21","author":"Rutten","year":"2019","journal-title":"Genet Med"},{"issue":"7","key":"noi220071r5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/jnnp-2020-325838","article-title":"NOTCH3 variants are more common than expected in the general population and associated with stroke and vascular dementia: an analysis of 200 000 participants.","volume":"92","author":"Cho","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"noi220071r6","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/brain\/awab253","article-title":"Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities.","volume":"144","author":"Malik","year":"2021","journal-title":"Brain"},{"issue":"6","key":"noi220071r7","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1161\/STROKEAHA.121.036307","article-title":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy family members with a pathogenic NOTCH3 variant can have a normal brain magnetic resonance imaging and skin biopsy beyond age 50 years.","volume":"53","author":"Hack","year":"2022","journal-title":"Stroke"},{"issue":"4","key":"noi220071r8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/STROKEAHA.109.568402","article-title":"Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals.","volume":"41","author":"Adib-Samii","year":"2010","journal-title":"Stroke"},{"issue":"11","key":"noi220071r9","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1161\/01.STR.0000245084.35575.66","article-title":"Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers.","volume":"37","author":"Opherk","year":"2006","journal-title":"Stroke"},{"issue":"3","key":"noi220071r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"noi220071r11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neuroimage.2017.10.034","article-title":"Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank.","volume":"166","author":"Alfaro-Almagro","year":"2018","journal-title":"Neuroimage"},{"issue":"9596","key":"noi220071r12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"noi220071r13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor.","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"7","key":"noi220071r14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","article-title":"Cadasil.","volume":"8","author":"Chabriat","year":"2009","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi220071r16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"noi220071r18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study.","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"noi220071r19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/nn.4393","article-title":"Multimodal population brain imaging in the UK Biobank prospective epidemiological study.","volume":"19","author":"Miller","year":"2016","journal-title":"Nat Neurosci"},{"issue":"1","key":"noi220071r20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.","volume":"17","author":"Smith","year":"2002","journal-title":"Neuroimage"},{"issue":"12","key":"noi220071r21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroimage.2016.07.018","article-title":"BIANCA (Brain Intensity AbNormality Classification Algorithm): a new tool for automated segmentation of white matter hyperintensities.","volume":"141","author":"Griffanti","year":"2016","journal-title":"Neuroimage"},{"issue":"4","key":"noi220071r22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ana.24758","article-title":"A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms.","volume":"80","author":"Baykara","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"noi220071r23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ima.v22.1","article-title":"MRtrix: diffusion tractography in crossing fiber regions.","volume":"22","author":"Tournier","year":"2012","journal-title":"Int J Imaging Syst Technol"},{"issue":"1","key":"noi220071r24","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-020-15932-3","article-title":"Genome-wide association study of MRI markers of cerebral small vessel disease in 42,310 participants.","volume":"11","author":"Persyn","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"noi220071r25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: uses and interpretations.","volume":"52","author":"Rubinov","year":"2010","journal-title":"Neuroimage"},{"issue":"1","key":"noi220071r26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"issue":"6","key":"noi220071r27","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1161\/STROKEAHA.119.028587","article-title":"Network efficiency mediates the relationship between vascular burden and cognitive impairment: a diffusion tensor imaging study in UK Biobank.","volume":"51","author":"Shen","year":"2020","journal-title":"Stroke"},{"issue":"4","key":"noi220071r28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/WNL.0000000000000612","article-title":"Structural network efficiency is associated with cognitive impairment in small-vessel disease.","volume":"83","author":"Lawrence","year":"2014","journal-title":"Neurology"},{"issue":"21","key":"noi220071r29","doi-asserted-by":"publisher","first-page":"e1898","DOI":"10.1212\/WNL.0000000000005551","article-title":"Longitudinal decline in structural networks predicts dementia in cerebral small vessel disease.","volume":"90","author":"Lawrence","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"noi220071r30","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1038\/s41467-019-13848-1","article-title":"Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke.","volume":"10","author":"Abraham","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"noi220071r31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates.","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"issue":"2","key":"noi220071r32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/CIRCRESAHA.119.315686","article-title":"Monogenic and polygenic contributions to atrial fibrillation risk: results from a national biobank.","volume":"126","author":"Choi","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"noi220071r33","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1038\/s41467-020-17374-3","article-title":"Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions.","volume":"11","author":"Fahed","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"noi220071r34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwg113","article-title":"Interaction as departure from additivity in case-control studies: a cautionary note.","volume":"158","author":"Skrondal","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"1","key":"noi220071r35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation.","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"noi220071r36","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1212\/WNL.0000000000010525","article-title":"Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance.","volume":"95","author":"Rutten","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"noi220071r37","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200015","article-title":"Frequency and phenotype associations of rare variants in 5 monogenic cerebral small vessel disease genes in 200,000 UK Biobank participants.","volume":"8","author":"Ferguson","year":"2022","journal-title":"Neurol Genet"},{"issue":"pt 9","key":"noi220071r38","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/brain\/awh223","article-title":"The influence of genetic and cardiovascular risk factors on the CADASIL phenotype.","volume":"127","author":"Singhal","year":"2004","journal-title":"Brain"},{"issue":"4","key":"noi220071r39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/ng1533","article-title":"Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia.","volume":"37","author":"Sebastiani","year":"2005","journal-title":"Nat Genet"},{"key":"noi220071r15","unstructured":"UniProt. Q9UM47: neurogenic locus notch homolog protein 3, homo sapiens (human) gene: NOTCH3. Accessed October 10, 2022. http:\/\/uniprot.org\/uniprot\/Q9UM47"},{"key":"noi220071r17","unstructured":"Ellard? S, Baple? EL, Berry? I, . ACGS Best Practice Guidelines for Variant Classification 2019. Ratified May 2019. https:\/\/www.acgs.uk.com\/media\/11285\/uk-practice-guidelines-for-variant-classification-2019-v1-0-3.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2797931\/jamaneurology_cho_2022_oi_220071_1670426902.97801.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T11:01:02Z","timestamp":1670842862000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2797931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.3832","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}